| 1 |
Asadi Mobarkhan FA, Manuylov VA, Karlsen AA, Kichatova VS, Potemkin IA, Lopatukhina MA, Isaeva OV, Mullin EV, Mazunina EP, Bykonia EN, Kleymenov DA, Popova LI, Gushchin VA, Tkachuk AP, Saryglar AA, Kravchenko IE, Sleptsova SS, Romanenko VV, Kuznetsova AV, Solonin SA, Semenenko TA, Mikhailov MI, Kyuregyan KK. Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination. Vaccines (Basel) 2023;11. [PMID: 36851307 DOI: 10.3390/vaccines11020430] [Reference Citation Analysis]
|
| 2 |
Aslam H, Oza F, Ahmed K, Kopel J, Aloysius MM, Ali A, Dahiya DS, Aziz M, Perisetti A, Goyal H. The Role of Red Cell Distribution Width as a Prognostic Marker in Chronic Liver Disease: A Literature Review. Int J Mol Sci 2023;24. [PMID: 36834895 DOI: 10.3390/ijms24043487] [Reference Citation Analysis]
|
| 3 |
Belota RCC, Silva JM, Nascimento EL, Abrahim CMM, Castilho MC, Neto JPM, Albuquerque SRL. Accuracy of screening for HBV (NAT, HBSAg, anti-HBC) in blood donors from the Brazilian Amazon from 2105 to 2018.. [DOI: 10.21203/rs.3.rs-2448104/v1] [Reference Citation Analysis]
|
| 4 |
Qi X, Dai J, Wang X, Wang M, Wang Y. Molecular evolutionary characteristics of OBI virus S gene among the adolescent population in rural and pastoral areas of Xinjiang Province. Infect Genet Evol 2023;107:105395. [PMID: 36503123 DOI: 10.1016/j.meegid.2022.105395] [Reference Citation Analysis]
|
| 5 |
Usman A, Shuaib BI, Musa BOP, Awwal S, Akogwu S. Seroprevalence of Occult Hepatitis B Virus Infection Using Anti-HBc and Nucleic Acid Amplification (HBV DNA) Technique in a Resource-Limited Setting: a Systematic Review and Meta-Analysis of Nigerian Literature. SN Compr Clin Med 2022;5:21. [DOI: 10.1007/s42399-022-01359-y] [Reference Citation Analysis]
|
| 6 |
Mohamed O, Ibrahim SAE, Mohamed SB, Kambal S, hamedelnile Y, Hassan M, Almofti YA, kafi S. Incidence of Occult Hepatitis B virus infection among Sudanese patient with Hepatocellular Carcinoma and Liver Cirrhosis in the absence of Hepatitis C virus.. [DOI: 10.21203/rs.3.rs-2320343/v1] [Reference Citation Analysis]
|
| 7 |
Jasleen Singh, Savina Stoitsova, Karolina Zakrzewska, Lukasz Henszel, Magdalena Rosińska, Erika Duffell. Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021. BMC Public Health 2022;22:2260. [PMID: 36463162 DOI: 10.1186/s12889-022-14726-0] [Reference Citation Analysis]
|
| 8 |
Cappy P, Boizeau L, Candotti D, Le Cam S, Martinaud C, Pillonel J, Tribout M, Maugard C, Relave J, Richard P, Morel P, Laperche S. Insights on 21 Years of HBV Surveillance in Blood Donors in France. Viruses 2022;14. [PMID: 36423116 DOI: 10.3390/v14112507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Faria ACD, Correa BHM, Faria LC, Vidigal PVT, Xavier MAP, Ferrari TCA. Occult hepatitis B virus infection in patients with chronic liver disease of different etiology in a Brazilian referral center: comparison of two different hepatitis B virus deoxyribonucleic acid amplification protocols: a cross-sectional study. Sao Paulo Med J . [DOI: 10.1590/1516-3180.2022.0147.r1.12072022] [Reference Citation Analysis]
|
| 10 |
Xie WY, Sun C, He H, Deng C, Sheng Y. Estimates of the prevalence of occult HBV infection in Asia: a systematic review and meta-analysis. Infect Dis (Lond) 2022;:1-16. [PMID: 36047593 DOI: 10.1080/23744235.2022.2115126] [Reference Citation Analysis]
|
| 11 |
Gebretsadik D, Assefa M, Fenta GM, Daba C, Ali A, Tekele SG, Masaki N. High Seroprevalence of Hepatitis B and C Virus Infections among Pregnant Women Attending Antenatal Clinic in Borumeda General Hospital, Northeast Ethiopia. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/1395238] [Reference Citation Analysis]
|
| 12 |
Lalana Garcés M, Ortiz Pastor O, Solé Enrech G, Guerra-ruiz AR, Casals Mercadal G, Almería Lafuente A, Ballesteros Vizoso MA, Medina PG, Salgüero Fernández S, Zamora Trillo A, Aured de la Serna I, Hurtado JC, Pérez-del-pulgar S, Forns X, Morales Ruiz M. Control of occult hepatitis B virus infection. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2022;0. [DOI: 10.1515/almed-2022-0065] [Reference Citation Analysis]
|
| 13 |
Lalana Garcés M, Pastor OO, Solé Enrech G, Guerra-ruiz AR, Mercadal GC, Almería Lafuente A, Ballesteros Vizoso MA, Medina PG, Salgüero Fernández S, Zamora Trillo A, Aured de la Serna I, Hurtado JC, Pérez-del-pulgar S, Forns X, Morales Ruiz M. Revisión de la infección oculta por el virus de la hepatitis B. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2022;0. [DOI: 10.1515/almed-2021-0084] [Reference Citation Analysis]
|
| 14 |
Gissa SB, Minaye ME, Yeshitela B, Gemechu G, Tesfaye A, Alemayehu DH, Shewaye A, Sultan A, Mihret A, Mulu A. Occult hepatitis B virus infection among patients with chronic liver disease of unidentified cause, Addis Ababa Ethiopia. Sci Rep 2022;12:13188. [PMID: 35915105 DOI: 10.1038/s41598-022-17336-3] [Reference Citation Analysis]
|
| 15 |
Saitta C, Pollicino T, Raimondo G. Occult Hepatitis B Virus Infection: An Update. Viruses 2022;14:1504. [PMID: 35891484 DOI: 10.3390/v14071504] [Reference Citation Analysis]
|
| 16 |
Gherlan GS. Occult hepatitis B — the result of the host immune response interaction with different genomic expressions of the virus. World J Clin Cases 2022; 10(17): 5518-5530 [DOI: 10.12998/wjcc.v10.i17.5518] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Biswas S, Rust LN, Wettengel JM, Yusova S, Fischer M, Carson JN, Johnson J, Wei L, Thode T, Kaadige MR, Sharma S, Agbaria M, Bimber BN, Tu T, Protzer U, Ploss A, Smedley JV, Golomb G, Sacha JB, Burwitz BJ. Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity. Nat Commun 2022;13:2995. [PMID: 35637225 DOI: 10.1038/s41467-022-30593-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Wang T, Shen C, Li H, Chen L, Liu S, Qi J. High resolution HLA-DRB1 analysis and shared molecular amino acid signature of DRβ1 molecules in Occult hepatitis B infection. BMC Immunol 2022;23:22. [PMID: 35468727 DOI: 10.1186/s12865-022-00496-2] [Reference Citation Analysis]
|
| 19 |
Wu J, Yu Y, Dai Y, Zhang Y, Cheng J, Cui D. Research Progress on the Mechanism of Persistent Low-Level HBsAg Expression in the Serum of Patients with Chronic HBV Infection. Journal of Immunology Research 2022;2022:1-11. [DOI: 10.1155/2022/1372705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Zhao M, Xu Y, Zhang D, Li G, Gao H, Zeng X, Tie Y, Wu Y, Dai E, Feng Z. Establishment and evaluation of a quadruple quantitative real-time PCR assay for simultaneous detection of human coronavirus subtypes. Virol J 2022;19. [DOI: 10.1186/s12985-022-01793-3] [Reference Citation Analysis]
|
| 21 |
Malik GF, Zakaria N, Majeed MI, Ismail FW. Viral Hepatitis - The Road Traveled and the Journey Remaining. Hepat Med 2022;14:13-26. [PMID: 35300491 DOI: 10.2147/HMER.S352568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Boumbaly S, Balde TAL, Semenov AV, Ostankova YV, Serikova EN, Naidenova EV, Valutite DE, Shchemelev AN, Zueva EB, Esaulenko EV, Totolian AA. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea]. Vopr Virusol 2022;67:59-68. [PMID: 35293189 DOI: 10.36233/0507-4088-92] [Reference Citation Analysis]
|
| 23 |
Shirmast P, Shahri MA, Pashangzadeh S, Mirshahabi H, Samadi E, Motamed N. Detection of occult hepatitis B virus in patients undergoing chemotherapy in Iran. Future Virology 2022;17:29-36. [DOI: 10.2217/fvl-2020-0386] [Reference Citation Analysis]
|
| 24 |
Sfeir MM, Snayd M. Serologic Testing for Hepatitis B. JAMA 2021;326:2423-4. [PMID: 34797375 DOI: 10.1001/jama.2021.19803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 25 |
Hu H, Shen Y, Hu M, Zheng Y, Xu K, Li L. Incidence and Influencing Factors of New Hepatitis B Infections and Spontaneous Clearance: A Large-Scale, Community-Based Study in China. Front Med (Lausanne) 2021;8:717667. [PMID: 34869415 DOI: 10.3389/fmed.2021.717667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 26 |
Wang H, Liao F, Xie J, Gao W, Wang M, Huang J, Xu R, Liao Q, Shan Z, Zheng Y, Rong X, Li C, Fu Y. E2 Site Mutations in S Protein Strongly Affect Hepatitis B Surface Antigen Detection in the Occult Hepatitis B Virus. Front Microbiol 2021;12:664833. [PMID: 34867835 DOI: 10.3389/fmicb.2021.664833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Zhou X, Zhang F, Ao Y, Lu C, Li T, Xu X, Zeng H. Diagnosis experiences from 50 hepatitis B patients in Chongqing, China: a qualitative study. BMC Public Health 2021;21:2195. [PMID: 34852813 DOI: 10.1186/s12889-021-11929-9] [Reference Citation Analysis]
|
| 28 |
de Almeida NAA, de Paula VS. Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review. J Appl Microbiol 2021. [PMID: 34724308 DOI: 10.1111/jam.15351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Azmoudeh-Ardalan F, Khodabandehloo M. Prevalence of Overt and Occult Hepatitis B Virus Infection among HIV-Positive People Referring to Consultation Center for Behavioral Diseases, Kurdistan Province, Iran. Iran Biomed J 2021;25:434-40. [PMID: 34717309 DOI: 10.52547/ibj.25.6.434] [Reference Citation Analysis]
|
| 30 |
Tsai YC, Sou FM, Liu YW, Wu YJ, Yong CC, Chen DW, Huang PY, Cho WR, Chuang CH, Hsiao CC, Hu TH, Tsai MC. Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection. BMC Gastroenterol 2021;21:386. [PMID: 34666694 DOI: 10.1186/s12876-021-01944-w] [Reference Citation Analysis]
|
| 31 |
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021;100:S1-S276. [PMID: 34556256 DOI: 10.1016/j.kint.2021.05.021] [Cited by in Crossref: 137] [Cited by in F6Publishing: 184] [Article Influence: 68.5] [Reference Citation Analysis]
|
| 32 |
Fiorino S, Tateo F, Biase D, Gallo CG, Orlandi PE, Corazza I, Budriesi R, Micucci M, Visani M, Loggi E, Hong W, Pica R, Lari F, Zippi M. SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses. Future Microbiol 2021;16:1105-33. [PMID: 34468163 DOI: 10.2217/fmb-2021-0064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 33 |
Enriquez-Navarro K, Maldonado-Rodriguez A, Rojas-Montes O, Torres-Ibarra R, Bucio-Ortiz L, De la Cruz MA, Torres-Flores J, Xoconostle-Cazares B, Lira R. Identification of mutations in the S gene of hepatitis B virus in HIV positive Mexican patients with occult hepatitis B virus infection. Ann Hepatol 2020;19:507-15. [PMID: 32592870 DOI: 10.1016/j.aohep.2020.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 34 |
Elbahrawy A, Ibrahim MK, Eliwa A, Alboraie M, Madian A, Aly HH. Current situation of viral hepatitis in Egypt. Microbiol Immunol 2021;65:352-72. [PMID: 33990999 DOI: 10.1111/1348-0421.12916] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 35 |
Fragkou N, Sideras L, Panas P, Emmanouilides C, Sinakos E. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence? World J Gastroenterol 2021; 27(27): 4252-4275 [PMID: 34366604 DOI: 10.3748/wjg.v27.i27.4252] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Silva RJS, do Nascimento RS, Oliveira-Neto JAJ, Silva FQ, Piauiense JNF, Gomes CM, Pinheiro LML, Resque RL, Pinho JRR, Kupek E, Fischer B, Machado LFA, Martins LC, Lemos JAR, Oliveira-Filho AB. Detection and Genetic Characterization of Hepatitis B and D Viruses: A Multi-Site Cross-Sectional Study of People Who Use Illicit Drugs in the Amazon Region. Viruses 2021;13:1380. [PMID: 34372586 DOI: 10.3390/v13071380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Delfino CM, Giorgio M, García G, Puch SS, Outon E, Mathet VL. Drug-resistant and immune-escape hepatitis B virus mutants, occult hepatitis B infection and coinfections in public hospital patients from Argentina. Virus Genes 2021;57:327-37. [PMID: 34091827 DOI: 10.1007/s11262-021-01850-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Li L. Association between the interferon-γ +874T/A polymorphism and susceptibility to hepatitis B virus infection: a meta-analysis. J Int Med Res 2020;48:300060520945511. [PMID: 32790527 DOI: 10.1177/0300060520945511] [Reference Citation Analysis]
|
| 39 |
Xu T, Wang P, Zheng X, Yan Z, Li K, Xu J, Jiang C, Zhu F. The therapeutic effects and mechanisms of Long Chai Fang on chronic hepatitis B. Ann Transl Med 2021;9:865. [PMID: 34164499 DOI: 10.21037/atm-21-1923] [Reference Citation Analysis]
|
| 40 |
Pak K, Ordway S, Torres D. Occult HBV Infection: A Case Series at a Military Treatment Facility. Mil Med 2020;185:e795-8. [PMID: 31681958 DOI: 10.1093/milmed/usz379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 41 |
Pruß A, Chandrasekar A, Sánchez-Ibáñez J, Lucas-Samuel S, Kalus U, Rabenau HF. Algorithms for the Testing of Tissue Donors for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus. Transfus Med Hemother 2021;48:12-22. [PMID: 33708048 DOI: 10.1159/000513179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Chuang YC, Chen YR, Kuo TH. Cryoglobulinemic glomerulonephritis with underlying occult HBV infection and Waldenström macroglobulinemia: A case report. Medicine (Baltimore) 2021;100:e24792. [PMID: 33607837 DOI: 10.1097/MD.0000000000024792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 43 |
Serikova EN, Semenov AV, Ostankova YV, Totolian AA. Method for detecting hepatitis B virus in blood plasma at low viral load using real-time PCR. Klin Lab Diagn 2021;66:59-64. [PMID: 33567175 DOI: 10.18821/0869-2084-2021-66-1-59-64] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 44 |
Molagic V, Popescu C, Tiliscan C, Arama V, Arama SS. Rapid loss of HBs antigen in patients with HBV reactivation and high level of transaminases during immunosuppressive therapy - case series. Revista Romana de Medicina de Laborator 2021;29:105-13. [DOI: 10.2478/rrlm-2020-0039] [Reference Citation Analysis]
|
| 45 |
Scotto G, Fazio V, Nicola C. Occult Hepatitis B Infection in Recent Immigrants to Italy: Occult B Infection in Immigrants. J Community Health 2020;45:357-62. [PMID: 31555924 DOI: 10.1007/s10900-019-00746-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 46 |
Sun X, Wang C, Wang B, Yang X, Xu H, Shen M, Zhu K. Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group. Infect Dis Obstet Gynecol 2020;2020:4305950. [PMID: 33380780 DOI: 10.1155/2020/4305950] [Reference Citation Analysis]
|
| 47 |
Yokoyama K, Yamauchi E, Uchida Y, Kitaguchi T, Fukuda H, Yamauchi R, Tsuchiya N, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F. Hepatitis B virus core–related antigen is useful for surveillance of hepatocellular carcinoma recurrence in a patient with occult hepatitis B virus infection: Case report. Clin Case Rep 2020;8:3031-3036. [DOI: 10.1002/ccr3.3360] [Reference Citation Analysis]
|
| 48 |
Eltom K, Albeely A, El Hussein ARM, Elkhidir IM, Enan K. Occult hepatitis B virus infection in Sudan: A systematic review and meta-analysis. JGH Open 2020;4:800-7. [PMID: 33102748 DOI: 10.1002/jgh3.12411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 49 |
Nakhaie M, Charostad J, Kaydani GA, Faghihloo E. The role of viruses in adenocarcinoma development. Infect Genet Evol 2020;86:104603. [PMID: 33091575 DOI: 10.1016/j.meegid.2020.104603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 50 |
Teh CP, Chook JB, Ngeow YF, Tong TYK, Tee KK, Bong JJ, Mohamed R. Primer and probe conservation issue in the quantification of hepatitis B virus DNA. Rev Med Virol 2021;31. [DOI: 10.1002/rmv.2182] [Reference Citation Analysis]
|
| 51 |
Hayat Davoudi G, Makvandi M, Teimoori A, Samarbafzade A, Biparva Haghighi S, Bavi A, Alavinejad P, Keyvani H. Frequency of OBI among Patients with Autoimmune Hepatitis. Asian Pac J Cancer Prev 2020;21:2555-9. [PMID: 32986352 DOI: 10.31557/APJCP.2020.21.9.2555] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 52 |
Wang H, Wang M, Huang J, Xu R, Liao Q, Shan Z, Zheng Y, Rong X, Tang X, Li T, Wang W, Li C, Fu Y. Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection. J Viral Hepat 2020;27:915-21. [PMID: 32336003 DOI: 10.1111/jvh.13309] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 53 |
Shrestha S, Mahatara S, Pun SB, Shrestha M, Napit R, Manandhar KD. Serological markers and molecular analysis of hepatitis B infection in a tertiary care hospital at Kathmandu, Nepal. Indian J Gastroenterol 2020;39:354-61. [PMID: 33037988 DOI: 10.1007/s12664-020-01051-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 54 |
Wang J, Liu Y, Liao H, Liu L, Chen R, Si L, Luo D, Huang B, Li L, Jiang J, Xu D. The sK122R mutation of hepatitis B virus (HBV) is associated with occult HBV infection: Analysis of a large cohort of Chinese patients. J Clin Virol 2020;130:104564. [PMID: 32763811 DOI: 10.1016/j.jcv.2020.104564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 55 |
Wang H, Xiang Y, Li X, Liu S, Liu L. High lymphocyte‑to‑monocyte ratio is associated with low α‑fetoprotein expression in patients with hepatitis B virus‑associated hepatocellular carcinoma. Mol Med Rep 2020;22:2673-84. [PMID: 32945410 DOI: 10.3892/mmr.2020.11387] [Reference Citation Analysis]
|
| 56 |
Gish RG, Basit SA, Ryan J, Dawood A, Protzer U. Hepatitis B Core Antibody: Role in Clinical Practice in 2020. Curr Hepatology Rep 2020;19:254-65. [DOI: 10.1007/s11901-020-00522-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 57 |
Geffert K, Maponga TG, Henerico S, Preiser W, Mongella S, Stich A, Kalluvya S, Mueller A, Kasang C. Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional study. BMC Infect Dis 2020;20:395. [PMID: 32503443 DOI: 10.1186/s12879-020-05096-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 58 |
Ibrahim SAE, Mohamed SB, Kambal S, Diya-Aldeen A, Ahmed S, Faisal B, Ismail F, Ibrahim A, Sabawe A, Mohamed O. Molecular Detection of Occult Hepatitis B virus in plasma and urine of renal transplant patients in Khartoum state Sudan. Int J Infect Dis 2020;97:126-30. [PMID: 32497807 DOI: 10.1016/j.ijid.2020.05.101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 59 |
Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, Laperche S. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon. Blood Transfus 2019;17:403-8. [PMID: 31846605 DOI: 10.2450/2019.0182-19] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 60 |
Fasakin KA, Ifeanyichukwu MO, Ibijola AA, Adeniyi AA, Ajetunmobi WA, Adebara IO, Ajayi OD, Esan AJ, Oyeleke KO, Omisakin CT. Isolated serum hepatitis B core antibody seropositivity: A diagnostic risk factor for occult hepatitis B infection. VOXS 2020;15:266-272. [DOI: 10.1111/voxs.12526] [Reference Citation Analysis]
|
| 61 |
Elalfy H, Besheer T, Elhammady D, El Mesery A, Shaltout SW, Abd El-Maksoud M, Amin AI, Bekhit AN, Abd El Aziz M, El-Bendary M. Pathological characterization of occult hepatitis B virus infection in hepatitis C virus-associated or non-alcoholic steatohepatitis-related hepatocellular carcinoma. World J Meta-Anal 2020; 8(2): 67-77 [DOI: 10.13105/wjma.v8.i2.67] [Reference Citation Analysis]
|
| 62 |
Pisaturo M, Onorato L, Russo A, Coppola N. Prevalence of occult HBV infection in Western countries. J Med Virol 2020. [PMID: 32275083 DOI: 10.1002/jmv.25867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 63 |
Hernández-Romano P, Hernández-Romano J, Torres-Hernández RM, González-Jiménez B, López-Balderas N. Occult hepatitis B infections and anti-HBc prevalence at a resource-limited blood bank in Mexico. Transfus Med 2020;30:396-400. [PMID: 32250006 DOI: 10.1111/tme.12681] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 64 |
Jamshidi S, Bokharaei-Salim F, Esghaei M, Bastani MN, Garshasbi S, Chavoshpour S, Dehghani-Dehej F, Fakhim S, Khanaliha K. Occult HCV and occult HBV coinfection in Iranian human immunodeficiency virus-infected individuals. J Med Virol. 2020;92:3354-3364. [PMID: 32232978 DOI: 10.1002/jmv.25808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 65 |
Ruiz-calero Cendrero RM, Cancho Castellano B, Martín Hidalgo-barquero MV, Cid Parra MC, Galán González J, Fernández Solís MA, Sánchez García O. When can it be useful to look for occult HBV in haemodialysis patients? Nefrología (English Edition) 2020;40:115-119. [DOI: 10.1016/j.nefroe.2020.03.008] [Reference Citation Analysis]
|
| 66 |
Ruiz-calero Cendrero RM, Cancho Castellano B, Martín Hidalgo-barquero MV, Cid Parra MC, Galán González J, Fernández Solís MA, Sánchez García O. ¿Cuándo puede ser útil buscar VHB oculto en pacientes en hemodiálisis? Nefrología 2020;40:115-119. [DOI: 10.1016/j.nefro.2019.07.001] [Reference Citation Analysis]
|
| 67 |
Asadi-Pooya AA, Bartolini L. Prevention and treatment of temporal lobe epilepsy: lessons from hepatitis B story! Int J Neurosci 2020;130:1151-5. [PMID: 32053411 DOI: 10.1080/00207454.2020.1730370] [Reference Citation Analysis]
|
| 68 |
Tang Y, Liu X, Lu X, He Q, Li G, Zou Y. Occult Hepatitis B Virus Infection in Maintenance Hemodialysis Patients: Prevalence and Mutations in "a" Determinant. Int J Med Sci 2020;17:2299-305. [PMID: 32922195 DOI: 10.7150/ijms.49540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 69 |
Low J, Lee L, Tan ML, Hong M, Chan S. Single Hepatitis B Booster Dose in High-risk Children with Suboptimal Surface Antigen Antibody Responses After 3-dose Primary Vaccine Series. Indian Pediatr 2020;57:68-69. [DOI: 10.1007/s13312-020-1708-y] [Reference Citation Analysis]
|
| 70 |
Piauiense JNF, Costa CCS, Silva RJS, Cardoso YMN, Di Miceli JFF, Resque RL, Lemos JAR, Fischer B, Pinho JRR, Kupek E, Martins LC, Oliveira-Filho AB. Hepatitis B Virus Infection among People Who Use Illicit Drugs: Prevalence, Genotypes and Risk Factors in the State of Amapá, Northern Brazil. Subst Use Misuse 2020;55:1633-9. [PMID: 32338560 DOI: 10.1080/10826084.2020.1756334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 71 |
Cruz GP, Sargento C, Ventura MC, Oliveira J, Saraiva da Cunha J. Occult hepatitis B infection by a recombinant D/C virus in an immunosuppressed patient. IDCases 2020;19:e00671. [PMID: 32226761 DOI: 10.1016/j.idcr.2019.e00671] [Reference Citation Analysis]
|
| 72 |
Wong LP. The Guerilla Tactics of Hepatitis B Virus in Hemodialysis: Fighting a Stubborn Foe. Kidney Medicine 2019;1:324-326. [DOI: 10.1016/j.xkme.2019.10.003] [Reference Citation Analysis]
|
| 73 |
Soriano V, Aguilera A, Gonzalez R, Gomez-Gallego F, Barea L, Treviño M, Corral O. Occult hepatitis B and HIV infection. Eur J Gastroenterol Hepatol 2019;31:1403-7. [PMID: 30969194 DOI: 10.1097/MEG.0000000000001417] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 74 |
Weis-Torres SMDS, Fitts SMF, Cardoso WM, Higa Junior MG, Lima LA, Bandeira LM, Castro VOL, Carneiro FA, Iglecias LMM, Cesar GA, Tanaka TSO, Puga MAM, Rezende GR, Croda J, Lago BV, Motta-Castro ARC. High level of exposure to hepatitis B virus infection in a vulnerable population of a low endemic area: A challenge for vaccination coverage. Int J Infect Dis 2020;90:46-52. [PMID: 31589921 DOI: 10.1016/j.ijid.2019.09.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 75 |
Garzillo EM, Arnese A, Coppola N, Corvino A, Feola D, Monaco MGL, Signoriello G, Marsella LT, Arena P, Lamberti M. HBV vaccination status among healthcare workers: A cross-sectional study. J Infect Prev 2020;21:23-7. [PMID: 32030100 DOI: 10.1177/1757177419873043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 76 |
Hao QQ, Wang QH, Xia W, Qian HZ. Circulating miRNA expression profile and bioinformatics analysis in patients with occult hepatitis B virus infection. J Med Virol 2020;92:191-200. [PMID: 31513283 DOI: 10.1002/jmv.25594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 77 |
He WQ, Chen XJ, Wen YQ, Li YZ, He H, Chen Q. Detection of Hepatitis B Virus-Like Nucleotide Sequences in Liver Samples from Murine Rodents and Asian House Shrews. Vector Borne Zoonotic Dis 2019;19:781-3. [PMID: 31216240 DOI: 10.1089/vbz.2018.2424] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 78 |
Mitsumoto-Kaseida F, Murata M, Takayama K, Toyoda K, Ogawa E, Furusyo N, Hayashi J. Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients. J Infect Chemother 2020;26:28-32. [PMID: 31279522 DOI: 10.1016/j.jiac.2019.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 79 |
Ciupe SM. Modeling the dynamics of hepatitis B infection, immunity, and drug therapy. Immunol Rev 2018;285:38-54. [PMID: 30129194 DOI: 10.1111/imr.12686] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 80 |
Chang JJ, Mohtashemi N, Bhattacharya D. Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era. Curr HIV/AIDS Rep 2018;15:172-81. [PMID: 29572624 DOI: 10.1007/s11904-018-0379-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 81 |
Pessoni GC, Marinho TA, Carneiro MMS, Martins RM, Soares CC, Silva LN, Matos MA, Arantes AM, Teles JA, Santos NC, Araujo Teles S. Hepatitis B virus infection among oncohematologic disease patients in Central Brazil: prevalence, risk factors and immunization. Hematol Transfus Cell Ther 2019;41:199-204. [PMID: 31036513 DOI: 10.1016/j.htct.2018.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 82 |
Soi V, Soman S. Preventing Hepatitis B in the Dialysis Unit. Adv Chronic Kidney Dis 2019;26:179-84. [PMID: 31202390 DOI: 10.1053/j.ackd.2019.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 83 |
Moayedi J, Moini M, Geramizadeh B, Malekhosseini SA, Yaghobi R. Seropositive Form of Occult Hepatitis B Virus Infection in Iranian Patients with Cryptogenic Liver Cirrhosis. Hepat Mon 2019;In Press. [DOI: 10.5812/hepatmon.84806] [Reference Citation Analysis]
|
| 84 |
Guang Y, Yuzhong L, Hui L. Establishment of an analysis model based on measurement of hepatitis B viral infection serum markers. BMC Infect Dis 2019;19:171. [PMID: 30777024 DOI: 10.1186/s12879-019-3813-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 85 |
Yamaji K, Kai K, Komukai S, Koga H, Ide T, Kawaguchi A, Noshiro H, Aishima S. Occult HBV infection status and its impact on surgical outcomes in patients with curative resection for HCV-associated hepatocellular carcinoma. Hepatobiliary Surg Nutr 2018;7:443-53. [PMID: 30652089 DOI: 10.21037/hbsn.2018.10.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 86 |
Shin S, Kang J, Lee KR, Shin GS, Kang J, Seo YI, Min H. Analysis of Reentry Test for the Donors Showing Reactivity or Grey Zone in a HBV Surface Antigen Assay by a Chemiluminescent Immunoassay. KJBT 2018;29:301-309. [DOI: 10.17945/kjbt.2018.29.3.301] [Reference Citation Analysis]
|
| 87 |
Bivigou-mboumba B. Human Immunodeficiency Virus-Hepatitis B Virus (HIV-HBV) Coinfection. Advances in HIV and AIDS Control 2018. [DOI: 10.5772/intechopen.78567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 88 |
Coffin CS, Fung SK, Alvarez F, Cooper CL, Doucette KE, Fournier C, Kelly E, Ko HH, Ma MM, Martin SR, Osiowy C, Ramji A, Tam E, Villeneuve JP. Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. CanLivJ 2018;1:156-217. [DOI: 10.3138/canlivj.2018-0008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 89 |
Nagashima S, Yamamoto C, Ko K, Chuon C, Sugiyama A, Ohisa M, Akita T, Katayama K, Yoshihara M, Tanaka J. Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination. Vaccine 2019;37:145-51. [PMID: 30449632 DOI: 10.1016/j.vaccine.2018.11.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 90 |
Malagnino V, Fofana DB, Lacombe K, Gozlan J. Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements. Open Forum Infect Dis 2018;5:ofy227. [PMID: 30324127 DOI: 10.1093/ofid/ofy227] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 91 |
Eshraghi Mosa Abadi B, Kandelouei T, Eslami G, Asli M, Vaezjalali M. Prevalence and Risk Factors for Occult Hepatitis B and HIV Infections Among HCV Infected Intravenous Drug Users, Tehran, Iran. Arch Clin Infect Dis 2018;13. [DOI: 10.5812/archcid.3075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 92 |
Wu CC, Chen YS, Cao L, Chen XW, Lu MJ. Hepatitis B virus infection: Defective surface antigen expression and pathogenesis. World J Gastroenterol 2018; 24(31): 3488-3499 [PMID: 30131655 DOI: 10.3748/wjg.v24.i31.3488] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 93 |
Lau KCK, Osiowy C, Giles E, Lusina B, van Marle G, Burak KW, Coffin CS. Deep sequencing shows low-level oncogenic hepatitis B virus variants persists post-liver transplant despite potent anti-HBV prophylaxis. J Viral Hepat 2018;25:724-32. [PMID: 29316067 DOI: 10.1111/jvh.12860] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 94 |
Joshi SS, Coffin CS. Hepatitis B virus lymphotropism: emerging details and challenges. Biotechnology and Genetic Engineering Reviews 2018;34:139-51. [DOI: 10.1080/02648725.2018.1474324] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 95 |
Elkochri S, Tagajdid MR, Abi R, Elannaz H, Lahlou Amine I. Hépatite B occulte : un diagnostic à ne pas méconnaître. Revue Francophone des Laboratoires 2018;2018:67-70. [DOI: 10.1016/s1773-035x(18)30151-5] [Reference Citation Analysis]
|
| 96 |
Wen X, Su H, Wang Y, Pu Z, Gao J, Ji Z, Yuan X, Li X, Zhang W, Zhang L, Long Y, Yan Y, Shao Z. Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, China. J Viral Hepat 2018;25:281-8. [PMID: 29032635 DOI: 10.1111/jvh.12805] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 97 |
Orlien SMS, Ismael NY, Ahmed TA, Berhe N, Lauritzen T, Roald B, Goldin RD, Stene-Johansen K, Dyrhol-Riise AM, Gundersen SG, Morgan MY, Johannessen A. Unexplained chronic liver disease in Ethiopia: a cross-sectional study. BMC Gastroenterol 2018;18:27. [PMID: 29439653 DOI: 10.1186/s12876-018-0755-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 98 |
Jia Z, Gong Y, Pi Y, Liu X, Gao L, Kang L, Wang J, Yang F, Tang J, Lu W, Li Q, Zhang W, Yan Z, Yu L. pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis. Mol Pharm 2018;15:53-62. [PMID: 29148802 DOI: 10.1021/acs.molpharmaceut.7b00709] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 99 |
Moghoofei M, Mostafaei S, Ashraf-Ganjouei A, Kavosi H, Mahmoudi M. HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis. Microb Pathog 2018;114:436-43. [PMID: 29223453 DOI: 10.1016/j.micpath.2017.12.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 100 |
Wang C, Xia B, Ning Q, Zhao H, Yang H, Zhao Z, Wang X, Wang Y, Yu Y, Zhang Y. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China. Ann Hematol 2018;97:453-7. [PMID: 29188315 DOI: 10.1007/s00277-017-3188-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 101 |
Zhu C, Zhu H, Song H, Xu L, Li L, Liu F, Liu X. Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3. Lipids Health Dis 2017;16:213. [PMID: 29132372 DOI: 10.1186/s12944-017-0607-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 102 |
Azizolahi B, Rajaei E, Taherkhani R, Makvandi M. Low detection of hepatitis B and occult hepatitis B infection in patients with rheumatic diseases. The Egyptian Rheumatologist 2017;39:239-243. [DOI: 10.1016/j.ejr.2017.04.009] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 103 |
Wang M, Wang Y, Feng X, Wang R, Zeng H, Qi J, Zhao H, Li N, Cai J, Qu C. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center. Int J Infect Dis. 2017;65:15-21. [PMID: 28935244 DOI: 10.1016/j.ijid.2017.09.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 104 |
Koshino Y, Shinozaki Y, Wada T. Occult Hepatitis B Virus Infection With Increased Virus DNA Levels in a Chronic Hemodialysis Patient. Ther Apher Dial 2018;22:91-2. [PMID: 28905484 DOI: 10.1111/1744-9987.12595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 105 |
Mirabet V, Álvarez M, Luis-Hidalgo M, Galán J, Puig N, Larrea L, Arbona C. Detection of hepatitis B virus in bone allografts from donors with occult hepatitis B infection. Cell Tissue Bank 2017;18:335-41. [PMID: 28748417 DOI: 10.1007/s10561-017-9644-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 106 |
Huang X, Ma C, Zhang Q, Shi Q, Huang T, Liu C, Li J, Hollinger FB. Impact of "a" determinant mutations on detection of hepatitis B surface antigen (HBsAg) in HBV strains from Chinese patients with occult hepatitis B. J Med Virol 2017;89:1796-803. [PMID: 28513915 DOI: 10.1002/jmv.24859] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 107 |
Borgia G, Maraolo AE, Gentile I. Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet. Infect Dis (Lond). 2017;49:584-587. [PMID: 28316268 DOI: 10.1080/23744235.2017.1303746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
